Compare SQNS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SQNS | DRIO |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 52.8M |
| IPO Year | 2011 | 2013 |
| Metric | SQNS | DRIO |
|---|---|---|
| Price | $2.86 | $6.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $20.33 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 30.4K | 17.1K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | $49.79 | $47.58 |
| P/E Ratio | ★ N/A | $3.90 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $2.38 | $5.84 |
| 52 Week High | $10.93 | $17.74 |
| Indicator | SQNS | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 42.29 |
| Support Level | $2.94 | $6.18 |
| Resistance Level | $3.20 | $8.01 |
| Average True Range (ATR) | 0.13 | 0.58 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 54.81 | 11.80 |
Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.